IE
TRIV

Israel Englander’s TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK TRIV Stock Holding History

Israel Englander’s Portfolio TRIV Stock Details TRIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q3 		– Sell
-16,700
Closed -$89K – 3971
2015
Q2 		$89K Buy
+16,700
New +$118K ﹤0.01% 3190
2014
Q4 		– Sell
-17,744
Closed -$257K – 4524
2014
Q3 		$257K Sell
17,744
-17,860
-50% -$259K ﹤0.01% 3210
2014
Q2 		$554K Buy
+35,604
New +$540K ﹤0.01% 2536

Other funds holding TRIV

NMC
NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.49B AUM 208.7% 1-Year Est. Return
Stifel Financial
Stifel Financial St. Louis, Missouri $120B AUM 27.84% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
USAA
United Services Automobile Association San Antonio, Texas $1.24B AUM 2.91% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $5.69B AUM 60.64% 1-Year Est. Return

Israel Englander's TRIV Position: Q3 2015 in Review

Israel Englander sold out of TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK (TRIV) in Q3 2015, closing a stake of 16,700 shares — an estimated $89K sold.

Israel Englander first reported a position in TRIV in Q2 2014 and held it in 3 quarters. The position peaked at $554K in Q2 2014. 26 funds tracked by Wall St. Rank hold TRIV as of Q3 2015.

  • Israel Englander reported no remaining TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position as of Q3 2015 after selling out during the quarter.
  • Israel Englander sold 16,700 TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK shares in Q3 2015, an estimated $89K.
  • Israel Englander first reported a position in TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK in Q2 2014 and held it in 3 quarters.
  • Israel Englander's TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK position peaked at $554K in Q2 2014.
  • 26 funds tracked by Wall St. Rank held TRIVASCULAR TECHONOLOGIES, INC, COMMON STOCK as of Q3 2015.

Based on Millennium Management's 13F filing for Q3 2015, filed 16 Nov 2015.